Vaccines in the Prevention of Viral Pneumonia - 27/09/17

Résumé |
Pneumonia is of great global public health importance. Viral infections play both direct and indirect parts in its cause across the globe. Influenza is a leading cause of viral pneumonia in both children and adults, and respiratory syncytial virus is increasingly recognized as causing disease at both extremes of age. Vaccination offers the best prospect for prevention but current influenza vaccines do not provide universal and durable protection, and require yearly reformulation. In the future, it is hoped that influenza vaccines will give better and universal protection, and that new vaccines can be found for other causes of viral pneumonia.
Le texte complet de cet article est disponible en PDF.Keywords : Influenza, Vaccination, Respiratory syncytial virus (RSV), Parainfluenza, Adenovirus, Lower respiratory tract infection (LRTI), Viral pneumonia
Plan
| Disclosure: P.J.M. Openshaw holds a Wellcome Trust grant (WP108516) supporting vaccine testing with Mucosis BV, and collaborates with GlaxoSmithKline on RSV disease. |
Vol 38 - N° 1
P. 155-169 - mars 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
